Autonomous Defense AI · $12.7B Valuation · USAF CCA Selected
Last updated: May 15, 2026 · Status: Pre-IPO · S-1: Not filed
The short version
Shield AI raised $2.25B at $12.7B valuation in April 2026 — a 140% valuation jump in one year. Revenue of $540M+ projected for 2026 (80% YoY growth). Selected for the USAF Collaborative Combat Aircraft (CCA) program, the Air Force's autonomous drone wingman initiative. No S-1 filed. IPO window: 2026–2027.
IPO Quick Facts
Field
Data
Company
Shield AI Inc.
Sector
Defense Tech / Autonomous AI Systems
Valuation
$12.7B (April 2026 funding round)
Total Raised
$2.25B ($1.5B in latest tranche + prior rounds)
2026 Revenue (projected)
$540M+ (~80% YoY growth)
Flagship Product
Hivemind — autonomous AI pilot for drones and aircraft
Strong revenue growth (80% YoY), government contract backlog, USAF CCA selection, and strategic acquisition. Held back by: no S-1, defense sector IPO complexity, export control considerations, and government budget dependence risk.
Why Shield AI is an IPO Candidate
Shield AI sits at the intersection of two of the most investable themes of 2026: defense technology and autonomous AI. The USAF's Collaborative Combat Aircraft (CCA) program — which Shield AI's X-BAT drone won — is one of the largest defense procurement programs in a generation. CCA aircraft are designed to fly alongside manned F-35s and F-16s as AI-controlled wingmen, multiplying combat effectiveness without putting pilots in danger.
The $12.7B valuation — up 140% in a single year — reflects Wall Street's growing appetite for defense tech. Anduril ($28B), Palantir ($100B+), and L3Harris have demonstrated that investors will pay growth-company multiples for defense AI. Shield AI's differentiation is Hivemind: its AI pilot has been demonstrated in dogfight simulations against human pilots, and the technology works in GPS-denied, communications-jammed environments — exactly the contested environment assumptions for a potential conflict in the Pacific.
Revenue at $540M+ (2026 projection) with 80% growth puts Shield AI firmly in IPO territory by revenue scale. The question is timing: defense tech IPOs require ITAR compliance audits, classified contract disclosures, and government review. The earliest plausible window is late 2026, more likely 2027.
Revenue & Contracts
Metric
Value
Notes
2026 Revenue (projected)
$540M+
~80% YoY growth
Contract Backlog
Large (undisclosed)
USAF CCA + Navy + allied nations
Primary Revenue Type
Government contracts
USAF, Navy, DoD primes
USAF CCA Selection
SELECTED ✓
X-BAT autonomous drone program
Aechelon Acquisition
Completed 2026
Visual simulation for AI training
IPO Timeline
2015–2022
Shield AI founded. Hivemind deployed with US Special Operations Forces in Syria. Grew to $100M+ revenue on USAF/Navy contracts.
2023–2024
Raised Series F at ~$5.3B valuation. Revenue grew significantly on expanding DoD contracts.
April 2026
Raised $2.25B total at $12.7B valuation — 140% valuation increase in ~12 months. Acquired Aechelon Technology.
May 2026 (NOW)
USAF CCA selected — X-BAT drone advancing through program milestones. $540M+ revenue projected for 2026.
Late 2026–2027 (Estimate)
Earliest S-1 filing window. ITAR compliance, classified contract disclosures, and DoD review add complexity vs. commercial IPOs.
Competitive Position
Shield AI's primary competitor for USAF CCA is General Atomics (which lost the CCA selection to Shield AI's X-BAT and Anduril's Fury). The broader defense autonomy space includes Anduril Industries ($28B valuation) and traditional primes like Boeing, Lockheed Martin, and Northrop Grumman. Shield AI's differentiation is Hivemind: its software-defined autonomy stack works without connectivity — unlike competitors who require ground control links that adversaries can jam.
The Aechelon acquisition adds visual simulation capabilities critical for AI training at scale. Synthetic data — rather than expensive live flight testing — is how Hivemind gets smarter. This is the same compute-leverage approach that makes autonomous vehicle companies defensible once training data scale is achieved.
Defense Tech IPO Watch
Track Shield AI IPO + Get Alerts
Monitor Shield AI's S-1 filing, USAF contract news, and secondary market availability. Updated when anything changes.
Shield AI has not announced an IPO date for 2026. After raising $2.25B at a $12.7B valuation in April 2026, the company is well-funded. With $540M+ projected 2026 revenue and 80% YoY growth, Shield AI is a strong IPO candidate for 2026–2027. No S-1 has been filed with the SEC.
Shield AI was valued at $12.7 billion in its April 2026 funding round — a 140% increase from its valuation approximately one year prior. The company raised $2.25 billion total in this round ($1.5B primary tranche plus additional tranches).
Hivemind is Shield AI's core autonomous AI pilot technology. It enables aircraft to fly and complete missions without GPS, communications links, or human pilots — working in the GPS-denied, communications-jammed environments expected in contested conflict zones. Hivemind has been tested on F-16 fighter jets in dogfight simulations and is integrated into the X-BAT drone for the USAF CCA program.
The USAF Collaborative Combat Aircraft (CCA) program is the Air Force's initiative to develop autonomous drone "wingmen" that fly alongside manned F-35s and F-16s. Shield AI's X-BAT drone was selected for the CCA program, alongside Anduril's Fury. General Atomics was not selected. CCA represents a major shift in how the Air Force thinks about air power: autonomous drones multiplying the effectiveness of manned fighters without risking pilots.
Shield AI is projecting $540M+ revenue for 2026, representing approximately 80% year-over-year growth. This is contract-based defense revenue from the US Air Force, US Navy, and allied nation contracts. The company's revenue backlog is supported by multi-year government contracts.
Shield AI shares may be available to accredited investors on secondary markets like Forge Global or EquityZen. No public offering is available. Given the recent $12.7B valuation round, pre-IPO shares represent significant risk at this price level. Track Shield AI's IPO status at TechStackIPO.